ReviewInternational journal of molecular sciences2021

Oral Semaglutide, the First Ingestible Glucagon-Like Peptide-1 Receptor Agonist: Could It Be a Magic Bullet for Type 2 Diabetes?

Hwi Seung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.